VanEck Biotech ETF (NASDAQ:BBH) offers concentrated exposure to the high-growth biotechnology industry, while Invesco S&P 500 Equal Weight Health Care ETF (NYSEMKT:RSPH) provides equal-weighted access across the broader healthcare sector. Investors seeking healthcare exposure must choose between deep specialization and broad diversification. The VanEck fund targets a narrow slice of genetic research and drug manufacturing, whereas the Invesco fund levels the playing field across 61 major healthcare companies within the S&P 500, balancing exposure between industry giants and mid-sized firms. Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
CryptoAlerta — análise de criptomoedas e mercado em tempo real